<DOC>
	<DOC>NCT00626249</DOC>
	<brief_summary>24 diabetics with mild &amp; moderate renal disease and 12 diabetics without renal disease. One screening, one dosing &amp; one follow-up visit with TechnosphereÂ® Inhalation Powder given at Visit 2 via MedToneÂ® Inhaler and PK testing at 26 designated time points</brief_summary>
	<brief_title>Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function</brief_title>
	<detailed_description>This Phase 1, single-dose trial is being conducted to determine if nephropathy affects the way the kidneys eliminate the byproducts of TechnosphereÂ® Inhalation Powder as compared to kidneys free of disease. This trial will test the safety, tolerability and pharmacokinetics of the study medication. The trial consists of a screening, dosing and a follow-up visit. Single dose administration of TechnosphereÂ® Inhalation Powder occurs at the dosing visit. (V2) with serum and urine PK testing .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Nonsmoking males and females, = 18 and = 80 years with a BMI of = 37 kg/m2 Type 1 or type 2 diabetic Subjects with mild or moderate DNP and subjects with normal renal function, based on GFR rate and albuminuria Normal pulmonary function and performance based on PFTs No history of COPD, asthma, or active respiratory infection; must be able to perform PFTs No dose and/or formulation changes within the preceding 6 weeks for any concomitant medications No clinically significant major organ/systemic disease No previous or current chemotherapy or radiation therapy that may result in pulmonary toxicity No clinically significant abnormalities on screening laboratory evaluation, except abnormal laboratory renal parameters in subjects with DNP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Nephropathy</keyword>
	<keyword>Kidney Disease</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Renal</keyword>
	<keyword>Diabetics</keyword>
</DOC>